KRKG logo

Krka, d. d. Stock Price

LJSE:KRKG Community·€7.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 48 Fair Values set on narratives written by author

KRKG Share Price Performance

€240.50
67.00 (38.62%)
€240.50
67.00 (38.62%)
Price €240.50

KRKG Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Solid track record with excellent balance sheet and pays a dividend.

0 Risks
4 Rewards

Krka, d. d. Key Details

€2.0b

Revenue

€858.0m

Cost of Revenue

€1.2b

Gross Profit

€779.8m

Other Expenses

€403.2m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 14, 2026
13.30
57.96%
19.76%
0.0001%
View Full Analysis

About KRKG

Founded
1954
Employees
11667
CEO
Jože Colaric
WebsiteView website
www.krka.biz

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company offers prescription pharmaceuticals for cardiovascular, central nervous system, gastrointestinal tract, pain, diabetes, and other therapeutic areas. It also provides non-prescription products for cough, cold, cerebral, peripheral circulation, gastrointestinal tract, metabolism, and other therapeutic areas, as well as analgesics, vitamins, minerals, and vasoprotectives. In addition, the company offers animal health products, including antiparasitics, antimicrobials, and other products. Further, it provides health resort and tourist services. The company was founded in 1954 and is based in Novo Mesto, Slovenia.

Recent KRKG News & Updates

Recent updates

No updates

Krka, d. d. Competitors